(Total Views: 436)
Posted On: 06/10/2025 5:33:34 PM
Post# of 154605
Go to Livimmune
r/Livimmune
•
1 hr. ago
BuildGoodThings
Setting the table and getting ready
I just took a break from preparing for guests tonight, and took a peek at investors hangout. My69z over there has been busy posting about the pooled data from 3 trials. They seem to believe there are 90 patients altogether in the 3 studies, and we've recently heard quite a bit about 28 of those that had TNBC.
I wanted to verify the idea that there are 90 patients in these studies. I'm not sure what sources My69z is using to arrive a figure of 90. I started pulling up information at clinicaltrials.gov, but it doesn't confirm that figure of 90 patients because study results of all of those 3 trials haven't been submitted there. However, I found this tidbit which is quite interesting-
It seems that yesterday June 9, 2025 CytoDyn submitted the trial results to clinicaltrials.gov on the Phase 1-2 mTNBC trial, "Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ mTNBC"
https://clinicaltrials.gov/study/NCT03838367?tab=results
IMO. CytoDyn is taking care of business, getting papers published, presenting at conferences, replicating earlier data, running clinical trials, establishing an oncology advisory board, etc.
I think there will be a busy summer because of new and old data analysis building a tremendous foundation.
r/Livimmune
•
1 hr. ago
BuildGoodThings
Setting the table and getting ready
I just took a break from preparing for guests tonight, and took a peek at investors hangout. My69z over there has been busy posting about the pooled data from 3 trials. They seem to believe there are 90 patients altogether in the 3 studies, and we've recently heard quite a bit about 28 of those that had TNBC.
I wanted to verify the idea that there are 90 patients in these studies. I'm not sure what sources My69z is using to arrive a figure of 90. I started pulling up information at clinicaltrials.gov, but it doesn't confirm that figure of 90 patients because study results of all of those 3 trials haven't been submitted there. However, I found this tidbit which is quite interesting-
It seems that yesterday June 9, 2025 CytoDyn submitted the trial results to clinicaltrials.gov on the Phase 1-2 mTNBC trial, "Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ mTNBC"
https://clinicaltrials.gov/study/NCT03838367?tab=results
IMO. CytoDyn is taking care of business, getting papers published, presenting at conferences, replicating earlier data, running clinical trials, establishing an oncology advisory board, etc.
I think there will be a busy summer because of new and old data analysis building a tremendous foundation.
(13)
(0)
